LIQUIDITY	3 Months Ended
Mar. 31, 2026
LIQUIDITY
LIQUIDITY	NOTE 2 - LIQUIDITY: At March 31, 2026 and December 31, 2025, the Company had cash and cash equivalents of $206,369 and $221,966, respectively, consisting of money market funds and U.S. Treasury Bills. Our net losses incurred for the three months ended March 31, 2026 and 2025, amounted to $153,777 and $14,507, respectively, and we had working capital of $201,898 and $217,495 at March 31, 2026 and December 31, 2025, respectively. Management believes that its cash and cash equivalents are sufficient for its business activities for at least the next twelve months and for the costs of seeking an acquisition of an operating business.

LIQUIDITY

3 Months Ended

Mar. 31, 2026

NOTE 2 - LIQUIDITY:

At March 31, 2026 and December 31, 2025, the Company had cash and cash equivalents of $206,369 and $221,966, respectively, consisting of money market funds and U.S. Treasury Bills. Our net losses incurred for the three months ended March 31, 2026 and 2025, amounted to $153,777 and $14,507, respectively, and we had working capital of $201,898 and $217,495 at March 31, 2026 and December 31, 2025, respectively. Management believes that its cash and cash equivalents are sufficient for its business activities for at least the next twelve months and for the costs of seeking an acquisition of an operating business.